Regulatory Risk Lessons from Former FDA Staff

Anna asks what former FDA members shared; Jonathan recounts critical perspectives and warns not to underestimate regulatory and manufacturing risks.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!